TRIUMF is in the midst of a multi-year effort to establish an Institute for Advanced Medical Isotopes (IAMI), which would feature major infrastructure for creating and handling these radioactive products, as well as laboratories for testing them in scientific and clinical settings. While similar work takes place in a variety of university and hospital settings across the country, this facility is intended to concentrate all aspects of such work — from the creation of raw materials to clinical trial work of potential therapies — in a single location...
Organizations: | IAMI, Institute for Advanced Medical Isotopes, TRIUMF, TRIUMF Innovations, and University of British Columbia |
People: | Jonathan Bagger, Kathryn Hayashi, and Paul Schaffer |
Topics: | medical isotopes and nuclear medicine |